De la Parra-Solomon is an entrepreneur focused on Information Technology, Education, and Health. He is creative, results-driven, and has 16+ years of Digital Strategy experience in architecture and implementation. De la Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions. He serves as COO and Co-founding Partner at The Solomon Brokerage Firm. He also leads as Vice President of Digital Strategy at Mass Media Division, while being the CEO of De la Parra Mobile Solutions. He is the former Vice President of Strategy and Operations PetroM Corp and its subdivision PetroM Logistics and PetroM Pharma, the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra-Solomon is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, De la Parra-Solomon acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, as a former member of the WAMS Executive Council (WAMS Executive Board), a former member of the WAMS Education & Training Board (ETB), a former member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & was also a Senior Partner at WAMS, The World Academy of Medical Sciences. He was also an Advisory Board member, functioned as the Chief Operating Officer and was a Co-founding Partner at The Reprogramming Medicine Association. De la Parra-Solomon is also a member of Singularity University and of OpenExo. In relation to the organizations that Mr. De la Parra has collaborated with for social impact and empowerment, he is a member of the Laurentia Project and of Cerebro Mexico, he serves as an Advisory Board member of the Lifeboat Foundation, as an Advisory Board member of the Future Worlds Center – Cyprus Neuroscience & Technology Institute (Senior TV Program), while also being a Federated Member of the International Longevity Alliance and a member of the Transhumanist Party. He is a voting citizen and is running for Mayor & future Parliamentary Candidate at Asgardia. He served as the Chief Digital Strategy Officer and is Member of the Board of Advisors and an Honorary Member at the Transdisciplinary Agora for Future Discussions, a member of the Web Committee at the Life Extension Advocacy Foundation/Lifespan.io, volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy, and acted as Digital Strategy adviser at the Major Mouse Testing Program. He also functioned as the founder and former Board of Directors member of Astrum Fundación and was Digital Strategy Advisor for POKI Ciudad Orgánica. He is also a part of the General Member Board at the National Autism Association, the National Fibromyalgia Association, the International Literacy Association, and the United Spinal Association. De la Parra-Solomon is also a member of several associations for technology including the World Blockchain Association, the EU Blockchain Observatory & Forum, the Blockchain Industry Group, the Computing Technology Industry Association, the Internet Marketing Association, the Application Developers Alliance, and the Association of Strategic Marketing. For the energy sector, he worked as the Vice President of Strategy & Operations of PetroM Energy and is a member of the National Introducing Brokers Association and a part of the National Biodiesel Board (Alliance Program). De la Parra-Solomon’s activities in arts & culture involve being a member of Sociedad de Autores y Compositores de México, while also being a member of the Executive Board at Sociedad Latinoamericana de Ópera. He also served as Digital Strategy Advisor at Xicome Festival. He is a media professional at IMDB, SoundCloud, and ReverbNation and has had activities in the entertainment industry as a music producer, composer & arranger for Televisa with broadcast television, film, radio, and web, receiving international awards with aired content in more than 185 countries.

Susanna Uusmaa is a biomedical scientist with broad expertise in Medical Sciences and in International Business. Holding an MSBS degree, she is result-driven to integrate modern smart technologies into making substantive contributions to the biomedical sector. Having conducted research in neuroscience and oncology and having proudly graduated from Tallinn University of Technology (TALTECH) and Tallinn University School of Natural Sciences and Health, Uusmaa takes an evidence-based approach to her professional objectives and also to her endeavors as a passionate healthy lifestyle entrepreneur. With a background in biomolecular and medical sciences, she has recently co-founded Quantum Brain Research Institute with the aim of supporting the development of neuroscientific research for neurocritical treatment applications through instructive programs in mental health assessment and management. In collaboration with the Luxembourg Institute of Health and Luxembourg Centre for Systems Biomedicine, she developed a complete standard operating procedure for differentiating and generating fully functional glial cells from induced pluripotent stem cells (iPSCs) in only 30 days. Moreover, she holds over 6 years of hard-working experience in business operations and relationship building in more than 5 countries around the globe, having created and nurtured mutually beneficial partnerships, enhanced workflow efficiency, and contributed to the growth of several initiatives with substantial savings. Ms. Uusmaa’s biomedical undertakings have positioned her as an MSBS to be able to become an active contributor also to the longevity sector and put her expertise into helping people become their best version of themselves with properly validated and ethical practices. She considers herself lucky to be born in the beautiful Northern European city of Tallinn in Estonia, a UNESCO World Heritage treasure of the Baltic Sea, where women’s rights are valued and where cutting-edge technologies are implemented in e-governance and healthcare. Uusmaa brings strong organizational and unique interpersonal abilities to her scope of action with the ultimate goal of integrating smart and efficient solutions to the biomedical sector and creating awareness of healthy living & healthy aging.

Sorush Niknamian MD Ph.D. CRFM PE APA_FPD OMS-IV AICP MWSES MLPI MACRO MTMA MRSB FIMS FChE EMBS FNNECOS FTSCO ANCC, AANP, ACPE, ACHE, ADA MCERP APA FMDCSCO FSASS SIAG/MPE - Ph.D. in Cell and Molecular Biology and Oncology and Professor of Cell and Molecular Biology, Oncology and Biological Attacks. He is a Professional Biologist, Senior Research Scientist, Chartered Scientist, and Registered His Science Council ID is: A-0008833. He is one of the United Kingdom and Indiana Cancer Consortium (ICC) certified. He is a Registered Researcher in the U.S. Government's System for Award Management, Registered Scientist at National Center for Biotechnology Information. He has studied Military Medicine at Liberty University (LU), Lynchburg, VA, United States of America. He holds Bachelor’s Degree in Mechatronics Engineering, Applied Mathematics, Civil Engineering, and Management. He is a Member of the US Government National Science Foundation, Member of Hera Swiss Volunteers (ID: 198036), Member of US Army American College of Physicians Chapter, Ambassador of the American Cancer Society (ACS CAN), and former Ambassador of European Association for Cancer Research (EACR), Active Member of Federal Health Professionals at US Army Forces and Certified Member of American Red Cross and Food Regulatory Affairs Professionals.

Azadeh Sepahvandi has a Ph.D. in Biomedical Engineering and two postdocs in Biomechanics. She has 7+ years of extensive exposure to Biomaterials, a number of publications in Tissue regeneration, and a worthwhile US patent in Retina Tissue Engineering. She is an instructor at the University of South Carolina.

Vinayak Asnotikar completed his M.Sc. Biotechnology with nearly 13 years of experience in QA/QC, Product Design & Development. he is adept at enhancing quality operations, optimizing resources & capacity, and escalating quality & operational efficiencies. His hands-on experience in working on Quality Assurance for USFDA, MHRA-UK, TGA-Australia, ANVISA-Brazil, GCC, MCC-South Africa, MOH-Oman, JFDA, and RVO-Germany approved Pharmaceutical formulation plants. he is expertise in working in the field of Pharma (injectable, Biotech, Diagnostic, Tablet Coating Industry(Excipients), Tablets, capsules, oral liquid, topical, steroid, Hormone, Antibiotic Plant, cGMP, and regulatory compliance requirements. he is deft in implementing cost reduction measures to achieve saving in terms of process improvements. he is an effective communicator with good logical, interpersonal and analytical skills, and he is a scientific bent of mind and the desire to explore.

Negin Samadi Kharajouei born in Tabriz , Iran. She is a 2nd-year Bsc student in Cellular and Molecular Biology at the Islamic Azad University of Tabriz Branch in Iran. Her first article titled "Effects of Music Therapy after Autologous Stem Cells" has been published at eight international conferences held in Iran, also under review at the Sydney Conference. She has worked on her Ph.D. thesis under the associate professor Dr. Nasirzadeh on Kidney issues.  This is her great honor to attend the Stem Cells Conference in Miami, USA as a speaker.

Poonam Yadav is a Ph.D. scholar, working in the Department of Research, Sir Ganga Ram Hospital and Amity University, Noida. She has 10 years of experience in the field of stem cell biology. Her main expertise is isolation, characterization, and cell-cell interaction assays of stem cells and tumor cells. Different sources like Bone marrow, Umbilical cord, Adipose tissue, and Dental pulp have been used to isolate & culture Mesenchymal Stem Cells(MSC). She is also in charge of the Good Manufacturing Practices (GMP) facility in Sir Ganga Ram Hospital. Her previous experience has been in the corporate (Cryoviva Biotech Pvt. Ltd. Gurugram) for 4 years and was responsible for quality maintenance of stem cell processing and storage. She has also published papers in international peer-reviewed journals and attended conferences and workshops in the area of clinical stem cell research. Presently her focus area is on pre-clinical stem cell transplant research and working on two human models to study the efficacy of stem cell transplant for Critical Limb Ischemia (CLI) and functional recovery in Diffused Traumatic brain injury (TBI).

Xiaoqiang Liu is a surgeon by profession and works in Tianjin Medical University General Hospital. He holds a doctoral degree and studied in Tokyo University of Japan for one year. He is mainly engaged in clinical work and basic research of urological oncology and andrology. He has made great contributions to the use of stem cells for the treatment of erectile dysfunction.

Renna Rathod Passionate Cell biology scientist with 13 years of experience in academia and industry in national and international settings. she has expertise in culturing and differentiation of human and mouse pluripotent stem cells into different cell types for disease modeling and regenerative purpose, Immuno-oncology (CAR-T), and Viral vector. With her Ph.D. from the University of Wuerzburg and other international collaborations, she has demonstrated the capacity to lead a team, work in a team environment as well as independently and bring several collaborations. 

Daniela Capdepon Graduate from the University of F. Medical Barceló in 2001 with honors and the highest academic average. She is a Residency in Internal Medicine at the  Campana, Zarate Municipal hospitals, Fundaleu, and COBA oriented Graduate Clinical Oncology 2002 – 2004. Daniela Capdepon has been working as a Medical physician for the last 20 years. Daniela Capdepon has been working as a Consultant Medical Oncologist for the last 15 years. Daniela Capdepon is very interested in the new advances in Oncology and everything related to my specialty and immunotherapy. As well as teaching. Daniela Capdepon would like to work in a University Hospital, where you can work and represent in the Congresses and Committees, the different jobs that are carried out and developed in the hospital. I am really interested in continuing to develop my career and progress in my profession.

Walaa is a microbiologist,  now she is a staff,  working in ADSCC as a volunteer for a Covid19, Walaa has a passion for improving health and wellbeing. She hopes that she will create new pathways for improving healthcare in her country for the people there and the surrounding world. Her first time to write or research to send for another always searching just to read it’s like a chance and challenge for her. Hope to communicate with someone who had experience and learn more from her/him with or without conference.

Sumaina Amin Completed BSc, in Biotechnology and Human Genetics from Doon College of paramedical science (Dehradoon), Central University. She Completed MSc in biotechnology and Human Genetics from Acharya College Bangalore University. She also did researches on swine flu from a Zoological Survey of India, Dehradun, Antibacterial property of lactic acid bacillus in probiotic milk, and Genomes from BARC Mumbai. She is Qualified in NET & JRF. She did Ph.D. in cancer oncology from stem cells at International University Bangalore, Bangalore. Currently with American Stress University as a research head guide and also working in Saudi Arabia as an Academic Dean.

Mahajan completed his master's in General Surgery from Marathwada University, Maharashtra, and went on to pursue Diploma in Urology at the University of Vienna, Austria. In a career-changing move, after three decades of being a successful general and uro-surgeon, he started his brainchild - StemRx Bioscience Solutions Pvt. Ltd. in the year 2011. This was to focus on in-depth research in the field of Regenerative Medicine and Cell-Based Therapy which he believes is the solution to address the limitations of conventional therapeutic modalities. To this effect, he underwent and continues to undergo intensive training in the United States. He has devised personalized treatment protocols in cell-based therapy for more than 75 health conditions.  Mahajan has published 20+ research articles in international and national journals. He has a patent for Avascular Necrosis and is on the board for reviewing scholarly articles for various international journals. Mahajan has received many international awards for his pioneering research work in regenerative medicine.

Abdul Qadir is a  Research assistant professor with in-depth knowledge and experience of stem cell, developmental biology, cancer, cancer stem cell, epigenetics, microRNA, and biomedical research. As a visiting assistant professor at the University of Illinois, his main focus is to develop iPSC-derived human vascularized lung organoids: for modeling homeostasis and Injury and resolution. During his postdoc at Northwestern University, he is focused on the mechanisms of Fas (CD95), a death receptor and Interferon mediated cancer stem cell formation. During his Ph.D., he has subsequently gained experience in the relationship between miRNA and Stem cell differentiation, especially towards osteogenesis, myogenesis, and adipogenesis.

For 25 years, he has been developing gene and cell therapy using non-human primates, immune-tolerant mice, and rats to protect against the side effects of radiation. He collaborates with clinicians to develop strategies for the treatment of patients after radiotherapy overexposures. He has participated in the first establishment of proof of concept of the therapeutic efficacy of mesenchymal stem cells (MSCs) for the treatment of hematopoietic deficit, radiodermatitis, and overdosages of radiotherapy. He has contributed to the first reported correction of deficient hematopoiesis in patients (graft failure and aplastic anemia) thanks to intravenous injection of MSCs restoring the bone marrow microenvironment, mandatory to sustain hematopoiesis after total body irradiation. He is the scientific investigator of Clinical phase II trial evaluating the efficacy of systemic MSC injections for the treatment of severe and chronic radiotherapy-induced abdominopelvic complications refractory to standard therapy

Chi Tang Tu graduated from National Taiwan University with a major in Molecular and Cellular Biology. During his postdoctoral research in the Surgery Department of National Taiwan University Hospital, he is specialized in the studies of adipose-derived stem cells and amnion stem cells for the disease of liver fibrosis/cirrhosis. Chi Tang Tu has his expertise in stem cells, mitochondria, CIK, and NK cells CMC-related activities, including development and manufacturing of drug substance, drug product, new chemically defined stem cell culturing, and conditioned medium, to support preclinical development through supplies for clinical phases. Many years experience of in managing and establishing GTP and PIC/S GMP facilities compliance with GLP, GTP, and PIC/S GMP. Furthermore, he led an intensive R&D team in the development of the isolation, scale-up, and cryopreservation process of mitochondria products (biologics) for augmenting therapy of neurodegenerative diseases and age-related infertility. His RD team built an innovative mitochondria functional analysis platform to assess cell drugs quality and to apply in blood BHI (bioenergetic health index) assay for preventive medicine. At the company, Chi Tang Tu also supports business and strategy development, patent deployment, engagement, and negotiation with venture capital or clients, and is in charge of translating our RD works from bench to bedside to business.

Sherko Nasseri completed Ph.D. in molecular medicine. Assistant Professor, from Kurdistan University of Medical Sciences, Iran. During my Ph.D. Thesis, I worked on the generation of Fam83h Knockout Mice by using the CRISPR/Cas9 method. The absence of Fam83h these mice has the scruffy cover, dry eye phenotypes, and also these mice were smaller than the same age normal mice. In continuation of this project, we found that the WNT/B-Catenin pathway decreased. The Fam83h gene has a high expression level in the gastrointestinal tract. Given all that has been said, it brings me a critical question that how does the fam83h gene play role in the gastrointestinal tract?

Arpit Sikri [BDS (Gold Medallist), MDS (Prosthodontics), PGDHM, DWCOI] is currently working as an Associate Professor & Post Graduate Teacher in the Department of Prosthodontics, Bhojia Dental College & Hospital, Baddi, Himachal Pradesh, India. He had earlier worked as Senior Resident in the most prestigious dental institute of the country i.e. Maulana Azad Institute of Dental Sciences, New Delhi, India. He had also worked as Senior Lecturer in Santosh Dental College, Santosh Deemed to be University, Ghaziabad (Delhi NCR) & Senior Lecturer in Sudha Rustagi College of Dental Sciences & Research, Faridabad, Haryana, India. He is the youngest dental surgeon of India to have completed his Post Graduate Diploma in Hospital Management from the National Institute of Health and Family Welfare (NIHFW, New Delhi), and that too with distinction. He has also been conferred with Diplomate Fellowship in the field of implantology by World Congress for Oral Implantology (WCOI), Tokyo, Japan. Throughout his academic career, he had been awarded gold medals being the Topper of the University, back to back. He has authored a book on “Oral Pathology” under Scientific Medtech publishers. He has to his credit around 28 books under Lambert Academic Publishing (LAP) and more than 100 national as well as international publications in various reputed journals. He is the Editor of Web med Central, Associate Editor of Current Dental Research Journal, and Assistant Editor of Asia Pacific Dental Journal & I-Dentistry journal. He is on the panel of various national and international journals as an editorial board member. Apart from this, he is also an active reviewer for various journals. He is actively associated with various associations namely IPS, IDA, IDRR, AHA, etc.

Sana Zahra has done MSc in Applied Biochemistry in 2010 (Gold Medalist). With a better record in earlier studies and interest in research, she is trying to get back into research even after a long-term gap in her studies.

Zeinab El-Zein has completed a master's degree in biochemistry from the Lebanese University faculty of sciences. Being a quality-oriented & talented Microbiology Supervisor with up to 8 years of experience in this field,  her expertise is particularly in the areas of quality management, auditing, compliance, quality improvement, and change processes. Throughout her career, she has held various positions. From this frame of reference, Zeinab El-Zein has a quick insight and overview in organizations related to processes and their link to quality.